Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 181 AL 195

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

Talbot K.

Neurodegener Dis Manag. 2014;4(1):31-40. doi: 10.2217/nmt.13.73.

Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer's disease susceptibility

Liu G, Li F, Zhang S, Jiang Y, Ma G, Shang H, Liu J, Feng R, Zhang L, Liao M, Zhao B, Li K.

Mol Neurobiol. 2014 Dec;50(3):757-64. doi: 10.1007/s12035-014-8670-4. Epub 2014 Mar 19.

From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Flaten V, Laurent C, Coelho JE, Sandau U, Batalha VL, Burnouf S, Hamdane M, Humez S, Boison D, Lopes LV, Buée L, Blum D.

Biochem Soc Trans. 2014 Apr;42(2):587-92. doi: 10.1042/BST20130229.

Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers

Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20.

Differential subtypes of diabetic older adults diagnosed with Alzheimer's disease

Sakurai T, Kawashima S, Satake S, Miura H, Tokuda H, Toba K.

Geriatr Gerontol Int. 2014 Apr;14 Suppl 2:62-70. doi: 10.1111/ggi.12250.

Deregulation of brain insulin signaling in Alzheimer's disease

Chen Y, Deng Y, Zhang B, Gong CX.

Neurosci Bull. 2014 Apr;30(2):282-94. doi: 10.1007/s12264-013-1408-x. Epub 2014 Mar 20.

Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease

Dorey E, Chang N, Liu QY, Yang Z, Zhang W.

Neurosci Bull. 2014 Apr;30(2):317-30. doi: 10.1007/s12264-013-1422-z. Epub 2014 Mar 20.

Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature

Lathe R, Sapronova A, Kotelevtsev Y.

BMC Geriatr. 2014 Mar 21;14:36. doi: 10.1186/1471-2318-14-36.

Social cognition in Alzheimer's disease: a separate construct contributing to dependence

Cosentino S, Zahodne LB, Brandt J, Blacker D, Albert M, Dubois B, Stern Y.

Alzheimers Dement. 2014 Nov;10(6):818-26. doi: 10.1016/j.jalz.2013.12.021. Epub 2014 Mar 18.

Pharmacotherapies for sleep disturbances in Alzheimer's disease

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.

Considering a new paradigm for Alzheimer's disease research

Langley GR.

Drug Discov Today. 2014 Aug;19(8):1114-24. doi: 10.1016/j.drudis.2014.03.013. Epub 2014 Mar 21.

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L.

J Alzheimers Dis. 2014;41(2):615-31. doi: 10.3233/JAD-132690.

Brain metabolite clearance: impact on Alzheimer's disease

Zolezzi JM, Inestrosa NC.

Metab Brain Dis. 2014 Sep;29(3):553-61. doi: 10.1007/s11011-014-9527-2. Epub 2014 Mar 25.

Oxidative stress in Alzheimer's disease

Chen Z, Zhong C.

Neurosci Bull. 2014 Apr;30(2):271-81. doi: 10.1007/s12264-013-1423-y. Epub 2014 Mar 24.

Environmental factors in the development and progression of late-onset Alzheimer's disease

Wainaina MN, Chen Z, Zhong C.

Neurosci Bull. 2014 Apr;30(2):253-70. doi: 10.1007/s12264-013-1425-9. Epub 2014 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias